Gelonghui, October 25th - Harbin Pharmaceutical Group (600664.SH) announced its third-quarter report, with revenue for the first three quarters at 12.256 billion yuan, a year-on-year increase of 6.63%, net income of 0.508 billion yuan, a year-on-year increase of 74.97%, non-GAAP net income of 0.47 billion yuan, a year-on-year increase of 91.39%, and basic earnings per share of 0.20 yuan.
哈药股份(600664.SH)：前三季净利润5.08亿元 同比增长74.97%
Harbin Pharmaceutical Group (600664.SH): net income of 0.508 billion yuan in the first three quarters, a year-on-year increase of 74.97%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated